Ads
related to: mds- Efficacy Data
Studied against the best available
therapies for myelofibrosis
- Dosing & Administration
Learn about dosing and
administration now
- Efficacy Data
Search results
Examinations of major salivary glands and heart reveal pathophysiological progression of Parkinson's
Medical Xpress· 5 days agoThis research outcome could potentially contribute to a better understanding of the...
Redington to team up with Hewlett Packard Enterprise on ‘Saudi Made’ servers
Gulf Business· 5 days agoRedington to sell and distribute Saudi-made servers from first of its kind facility in Saudi Arabia
Physical medicine and rehabilitation specialist Niriksha Malladi named a Castle Connolly Top Doctor
Digital Journal· 2 days agoAbout Castle Connolly Castle Connolly publishes its Top Doctors list at castleconnolly.com and in a variety of print and online partner publications. Nominations are open to all board-certified ...
Carl Sandburg, Galesburg, recognizes faculty, staff
WHBF Davenport via Yahoo News· 7 days agoCarl Sandburg College recognized the 2024 winners for Faculty of the Year, Adjunct Faculty of the Year and Staff Member of the Year during its recent...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 2 days ago– Study Achieved the Primary Endpoint; Mitapivat Demonstrated a Statistically Significant Transfusion Reduction Response Compared to Placebo – – Statistical Significance Achieved for All Key Secondary Endpoints Evaluating Additional Measures
How To Lower the Humidity in Your House With Ease on Your Own According to Experts
The Sacramento Bee· 5 days agoIdeally, humidity levels in the home should be about 35 to 45% in summer and 30 to 40% in winter. ”Today’s super-insulated homes are great at conserving energy, but they’re so tightly buttoned-up ...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 6 days agoJasper is a clinical-stage biotechnology company developing briquilimab, a monoclonal antibody targeting c-Kit (CD117) as a therapeutic for chronic mast and stem cell diseases such as chronic ...
Small Business - Picayune Item | Picayune Item
The Picayune Item· 2 days agoFlamingo Therapeutics Presents Poster at ASCO 2024 on Phase II PEMDA-HN Trial for Head and Neck Squamous Cell Carcinoma (HNSCC) PR Newswire LEUVEN, Belgium and STRASBOURG, France and PHILADELPHIA, June 2, 2024 -Trial-in-Progress poster provides